Phase 1 Clinical Study of ESO-T01 Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Researchers at Wuhan Union Hospital in China have published extended follow-up data on ESO-T01, a third-generation, in vivo B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR-T) therapy evaluated in ... Read More